• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.13 Down 0.28(4.37%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.41
    Open:6.41
    Bid:5.98 x 400
    Ask:6.19 x 3000
    1y Target Est:7.00
    Beta:0.9
    Earnings Date:Aug 17 - Aug 21 (Est.)
    Day's Range:6.09 - 6.41
    52wk Range:6.09 - 10.26
    Volume:4,912,305
    Avg Vol (3m):3,047,140
    Market Cap:1.01B
    P/E (ttm):3.20
    EPS (ttm):1.92
    Div & Yield:0.60 (9.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 4.37%1.01B
    AMGNDown 1.12%116.53B
    SGENDown 0.36%5.95B
    XOMADown 0.67%438.86M

    Key Statistics

    Forward P/E (1 yr):9.43
    P/S (ttm):2.11
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.11
    Quarterly EPS Est (Jun-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback